Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dietary Management

- PMLiVE

People buy people: mergers and acquisitions in medical communications

By Liz Jackson

- PMLiVE

Moving beyond vanilla to improve patient diversity in clinical trials

By Stephen O’Farrell

- PMLiVE

Can the patient pathway provide a route to success?

Why pharma companies need to identify barriers and co-create solutions along the patient pathway to ensure their new products reach the patients who need them

- PMLiVE

Novartis to acquire Chinook Therapeutics for approximately $3.5bn

The deal marks a notable expansion to the Swiss drugmaker's kidney disease pipeline

Biogen Idec building

Biogen/Eisai’s Alzheimer’s drug backed by FDA advisory committee for traditional approval

Leqembi was granted accelerated approval by the FDA in January for patients with early AD

- PMLiVE

AstraZeneca and Quell announce autoimmune disease partnership worth over $2bn

The collaboration will initially focus on developing cell therapies for type 1 diabetes and IBD

- PMLiVE

Mental health in the workplace: an outdated concept?

By Laura Glover

- PMLiVE

Inequality, inequity, disparity…

By Tim Cockroft

- PMLiVE

Improving remote communication skills in a digital environment

By Niamh Mangan

- PMLiVE

Intersectional health equity starts with diversity in clinical trials

By Jessica Pacey

- PMLiVE

There’s always one more thing to learn

The importance of continuing professional development and achieving learning objectives

EU flag

European Commission grants two new marketing authorisations for UCB’s Bimzelx

The drug is now approved to treat psoriatic arthritis and axial spondyloarthritis

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links